Author

Akash R. Boda

The University of Texas MD Anderson Cancer CenterORCID 0000-0001-6250-0498Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Irfan N. BandeyiD· 1 shared Jason RoszikiD· 1 shared Manisha SinghiD· 1 shared Michael A. CurraniD· 1 shared Natalie Wall FowlkesiD· 1 shared Sadhna AggarwaliD· 1 shared Saikat ChowdhuryiD· 1 shared Scott KopetziD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Irfan N. BandeyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 23, 2025

IL-1R1 Blockade Enhances CD40 Agonist-Mediated Immune Responses but Fails to Increase Efficacy or Mitigate Hepatotoxicity in Pancreatic Cancer

Akash R. Boda, Irfan N. Bandey, Saikat Chowdhury…·Manisha Singh

This study investigates the effect of IL-1R1 blockade on CD40 agonist therapy in PDAC, finding it does not improve efficacy and worsens liver toxicity.

1 citation

mouseexperimental assay

𝕏 PostBluesky